Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.136 | 0.3916 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.2265 | 0.9749 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2304 | 1 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.136 | 0.3916 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.136 | 0.3916 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.2304 | 1 | 1 |
Onchocerca volvulus | 0.2304 | 1 | 0.5 | |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.2265 | 0.9749 | 0.9706 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2304 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0752 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.2265 | 0.9749 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.2304 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2265 | 0.9749 | 0.9749 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2304 | 1 | 1 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.2304 | 1 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2265 | 0.9749 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.1321 | 0.3666 | 0.3666 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.2304 | 1 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.136 | 0.3916 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.136 | 0.3916 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.